Evidence map›Paper›PMID 34404533›Full record

ReviewBest practice & research. Clinical haematology2021

Somatic mosaicism in inherited bone marrow failure syndromes.

Fernanda Gutierrez-Rodrigues, Sushree S Sahoo, Marcin W Wlodarski, Neal S Young

Open access · greenAbstract readReview
In one paragraph

Review in Best practice & research. Clinical haematology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 22 citations in OpenAlex.

  1. Trial
  2. Clonal Signatures of Telomere Biology Disorders.Current hematologic malignancy reports · 2026
    Review
  3. Article
  4. Molecular diagnostics 101: how to use genetic tests in classical hematology.Hematology. American Society of Hematology. Education Program · 2025
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. When to consider inherited marrow failure syndromes in adults.Hematology. American Society of Hematology. Education Program · 2023
    Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Fernanda Gutierrez-RodriguesHematology Branch, National Heart, Lung, and Blood Institute (NHLBI), NIH, Bethesda, MD, USA. Electronic address: fernanda.rodrigues@nih.gov.
Sushree S SahooDepartment of Hematology, St. Jude Children's Research Hospital, TN, USA.
Marcin W WlodarskiDepartment of Hematology, St. Jude Children's Research Hospital, TN, USA; Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, University of Freiburg, Germany.
Neal S YoungHematology Branch, National Heart, Lung, and Blood Institute (NHLBI), NIH, Bethesda, MD, USA.
National Heart Lung and Blood Institute · USSt. Jude Children's Research Hospital · USUniversity of Freiburg · DE

Funding

Intramural NIH HHS Z99 HL999999
6 · The paper itself

Abstract

Inherited bone marrow failure syndromes (IBMFS) are a heterogenous group of diseases caused by pathogenic germline variants in key pathways associated with haematopoiesis and genomic stability. Germline variants in IBMFS-related genes are known to reduce the fitness of hematopoietic stem and progenitor cells (HSPC), which has been hypothesized to drive clonal selection in these diseases. In many IBMFS, somatic mosaicism predominantly impacts cells by two distinct mechanisms, with contrasting effects. An acquired variation can improve cell fitness towards baseline levels, providing rescue of a deleterious phenotype. Alternatively, somatic mosaicism may result in a fitness advantage that results in malignant transformation. This review will describe these phenomena in IBMFS and delineate their relevance for diagnosis and clinical management. In addition, we will discuss which samples and methods can be used for detection of mosaicism according to clinical phenotype, type of mosaicism, and sample availability.

Indexed as

Bone Marrow DiseasesMosaicismCell Transformation, NeoplasticCongenital Bone Marrow Failure SyndromesHematopoiesisHematopoietic Stem CellsHumansClonal haematopoiesisInherited bone marrow failure syndromesMosaicism

Identifiers

PMID34404533
PMCPMC8374086
OpenAlexW3176023484

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.